GlassScriptPhysician profile
Tiara Tolbert
NPI 1518613892
$1,110.84
in general payments reported to CMS, 2019-2025
14 companies · $434 in 2025
The $434 reported for 2025 was more than what 78% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.94 · 2023: $334 · 2024: $243 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.91 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $419.24 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $180.79 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $127.02 | 2022-2025 | |
| Sage Therapeutics, LLC | $105.51 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $52.29 | 2025 | Qelbree |
| Evofem Biosciences, INC. | $45.72 | 2025 | Solosec, Phexx, Phexxi |
| Hologic Sales and Service, LLC | $44.71 | 2025 | Aptima |
| Organon LLC | $23.95 | 2024 | |
| Mylan Pharmaceuticals INC. | $21.45 | 2022 | |
| Scynexis, INC. | $21.42 | 2022 | |
| Merck Sharp & Dohme LLC | $20.82 | 2025 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $18.23 | 2022 | |
| Abbvie INC. | $16.24 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $13.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiara Tolbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.